צמיחת הכנסות משנה לשנה ב-12 החודשים האחרונים: Syros Pharmaceuticals, Inc (SYRS)

Syros Pharmaceuticals (SYRS) is a recognized leader in gene reprogramming for the fight against oncology. While clinical trials currently limit pricing power, the company relies on strategic partnerships to maintain capital. The TTM revenue growth rate compared to last year reflects current resilience, with the value of -62.30 characterizing this level of business development.
syros.com - פילוחים אנליטיים ומדדי מפתח (SYRS)

This indicator measures annual revenue dynamics over a rolling 12-month period, allowing investors to assess the actual pace of business scaling by comparing current flows with the same window from the previous year. By analyzing the historical year-over-year revenue growth trend over the last 12 months, one can track the financial returns from the strategic alliances of Syros Pharmaceuticals (SYRS) in the development of targeted leukemia drugs.